However, the use of celastrol also demonstrated similarities to two out of three of the examined FDA-approved RA drugs (methotrexate and tocilizumab) in terms of the expression of some genes for example BMP1 and ERBB2 which support the therapeutic potency of celastrol in RA treatment. The gene discussed is ERBB2; the disease is rheumatoid arthritis.